Prime Medicine Inc
NASDAQ:PRME
Intrinsic Value
The intrinsic value of one PRME stock under the Base Case scenario is 1.2 USD. Compared to the current market price of 4.99 USD, Prime Medicine Inc is Overvalued by 76%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Prime Medicine Inc
Loading...
Fundamental Analysis

Revenue & Expenses Breakdown
Prime Medicine Inc
Balance Sheet Decomposition
Prime Medicine Inc
Current Assets | 121.3m |
Cash & Short-Term Investments | 101.8m |
Receivables | 120k |
Other Current Assets | 19.4m |
Non-Current Assets | 157.7m |
PP&E | 144m |
Other Non-Current Assets | 13.7m |
Free Cash Flow Analysis
Prime Medicine Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Prime Medicine Inc
Revenue
|
5m
USD
|
Operating Expenses
|
-209.2m
USD
|
Operating Income
|
-204.2m
USD
|
Other Expenses
|
4.9m
USD
|
Net Income
|
-199.3m
USD
|
PRME Profitability Score
Profitability Due Diligence
Prime Medicine Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.
Score
Prime Medicine Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.
PRME Solvency Score
Solvency Due Diligence
Prime Medicine Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Score
Prime Medicine Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PRME Price Targets Summary
Prime Medicine Inc
According to Wall Street analysts, the average 1-year price target for PRME is 7.43 USD with a low forecast of 4.04 USD and a high forecast of 10.5 USD.
Dividends
Current shareholder yield for PRME is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one PRME stock under the Base Case scenario is 1.2 USD.
Compared to the current market price of 4.99 USD, Prime Medicine Inc is Overvalued by 76%.